Effects of disease modifying anti-rheumatic agents on class II antigen expression.
Moodley
I
I
May and Baker Ltd., Dagenham, Essex, UK.
Foster
M
M
D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001310:Auranofin / Q000494:pharmacology; D002460:Cell Line; D003907:Dexamethasone / Q000494:pharmacology; D006684:HLA-DR Antigens / Q000276:immunology*; D015804:HLA-DR4 Antigen; D006801:Humans; D010396:Penicillamine / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D006684:HLA-DR Antigens; D015804:HLA-DR4 Antigen; D001310:Auranofin; D003907:Dexamethasone; D010396:Penicillamine